Alimentiv Health Trust Launches AcelaBio (US) Inc. Today

London, ON, CANADA, Release: April 14, 2021 – Alimentiv Health Trust, the parent company of Alimentiv, Inc. (formerly Robarts Clinical Trials), a specialized global gastrointestinal (GI) contract research organization (CRO), and McDougall Scientific Ltd., a niche CRO, announced today the launch of AcelaBio, a commercial state-of-the-art research laboratory delivering histopathology and precision medicine services for… Continue reading Alimentiv Health Trust Launches AcelaBio (US) Inc. Today

Precision Medicine in IBD – From Clinical Research to Clinical Practice

Dr. Séverine Vermeire, Dr. Deanna Nguyen, and Dr. Niels Vande Casteele present Precision Medicine in IBD Clinical Research. Dr. Vermeire presenting how a translational medicine program successfully supported the development of a new compound – a gut-selective pan-Janus kinase inhibitor. Dr. Nguyen presenting The Application of Translational Medicine to Support an Early Drug Development Program… Continue reading Precision Medicine in IBD – From Clinical Research to Clinical Practice